320 related articles for article (PubMed ID: 9834080)
21. Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis.
Hashim GA; Vandenbark AA; Galang AB; Diamanduros T; Carvalho E; Srinivasan J; Jones R; Vainiene M; Morrison WJ; Offner H
J Immunol; 1990 Jun; 144(12):4621-7. PubMed ID: 1693637
[TBL] [Abstract][Full Text] [Related]
22. Encephalitogenic T cell clones with variant receptor specificity.
Offner H; Hashim GA; Chou YK; Celnik B; Jones R; Vandenbark AA
J Immunol; 1988 Dec; 141(11):3828-32. PubMed ID: 2460551
[TBL] [Abstract][Full Text] [Related]
23. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.
Schluesener HJ; Wekerle H
J Immunol; 1985 Nov; 135(5):3128-33. PubMed ID: 2413113
[TBL] [Abstract][Full Text] [Related]
24. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells.
Nag B; Kendrick T; Arimilli S; Yu SC; Sriram S
Cell Immunol; 1996 May; 170(1):25-33. PubMed ID: 8660796
[TBL] [Abstract][Full Text] [Related]
25. Self and non-self peptides treat autoimmune encephalomyelitis: T cell anergy or competition for major histocompatibility complex class II binding?
Gautam AM
Eur J Immunol; 1995 Jul; 25(7):2059-63. PubMed ID: 7542603
[TBL] [Abstract][Full Text] [Related]
26. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice.
Offner H; Adlard K; Bebo BF; Schuster J; Burrows GG; Buenafe AC; Vandenbark AA
J Immunol; 1998 Sep; 161(5):2178-86. PubMed ID: 9725209
[TBL] [Abstract][Full Text] [Related]
27. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
28. A TCR V alpha CDR3-specific motif associated with Lewis rat autoimmune encephalomyelitis and basic protein-specific T cell clones.
Buenafe AC; Tsu RC; Bebo B; Bakke AC; Vandenbark AA; Offner H
J Immunol; 1997 Jun; 158(11):5472-83. PubMed ID: 9164970
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats.
Stepaniak JA; Gould KE; Sun D; Swanborg RH
J Immunol; 1995 Sep; 155(5):2762-9. PubMed ID: 7544385
[TBL] [Abstract][Full Text] [Related]
30. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles.
Mustafa M; Vingsbo C; Olsson T; Issazadeh S; Ljungdahl A; Holmdahl R
J Immunol; 1994 Oct; 153(7):3337-44. PubMed ID: 7522259
[TBL] [Abstract][Full Text] [Related]
31. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein.
Mannie MD; Paterson PY; U'Prichard DC; Flouret G
J Immunol; 1989 Apr; 142(8):2608-16. PubMed ID: 2467932
[TBL] [Abstract][Full Text] [Related]
32. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
Javed NH; Gienapp IE; Cox KL; Whitacre CC
J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
[TBL] [Abstract][Full Text] [Related]
33. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.
Grogan JL; Kramer A; Nogai A; Dong L; Ohde M; Schneider-Mergener J; Kamradt T
J Immunol; 1999 Oct; 163(7):3764-70. PubMed ID: 10490973
[TBL] [Abstract][Full Text] [Related]
34. T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein.
Zamvil SS; Mitchell DJ; Moore AC; Schwarz AJ; Stiefel W; Nelson PA; Rothbard JB; Steinman L
J Immunol; 1987 Aug; 139(4):1075-9. PubMed ID: 2440944
[TBL] [Abstract][Full Text] [Related]
35. Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes.
Bischof F; Wienhold W; Wirblich C; Malcherek G; Zevering O; Kruisbeek AM; Melms A
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12168-73. PubMed ID: 11593032
[TBL] [Abstract][Full Text] [Related]
36. Lewis rat T cells can reutilize, process, and present myelin basic protein to antigen-specific T cell lines.
St Louis JM; Pasick JM; Stein C; Freeman D; Singh B; Dales S; Strejan GH
Cell Immunol; 1994 Jun; 156(1):36-53. PubMed ID: 7515332
[TBL] [Abstract][Full Text] [Related]
37. Modulation of experimental autoimmune encephalomyelitis by administration of cells expressing antigenic peptide covalently linked to MHC class II.
Weishaupt A; Kreiss M; Gold R; Herrmann T
J Neuroimmunol; 2004 Jul; 152(1-2):11-9. PubMed ID: 15223233
[TBL] [Abstract][Full Text] [Related]
38. Myelin basic protein peptide complexes with the class II MHC molecules I-Au and I-Ak form and dissociate rapidly at neutral pH.
Mason K; Denney DW; McConnell HM
J Immunol; 1995 May; 154(10):5216-27. PubMed ID: 7537302
[TBL] [Abstract][Full Text] [Related]
39. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
[TBL] [Abstract][Full Text] [Related]
40. Response of rat encephalitogenic T lymphocyte lines to synthetic peptides of myelin basic protein.
Offner H; Hashim G; Vandenbark AA
J Neurosci Res; 1987; 17(4):344-8. PubMed ID: 2442405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
